Skip to main content
. 2021 Jun 14;16:275. doi: 10.1186/s13023-021-01907-0

Table 1.

Survival of the cohort at 1, 5 and 10 years from diagnosis for the total number of cases and for each nosological group

CASES (n) Age at diagnosis (mean ± standard deviation) % males 1 year 95% CI 5 years 95% CI 10 years 95% CI
Peripheral and central nervous system disorders 5928 53.0 ± 21.3 51.6 0.953 0.948–0.959 0.796 0.785–0.807 0.679 0.664–0.694
Congenital anomalies, chromosomal aberrations and genetic syndromesa 2377 17.4 ± 18.2 51.5 0.998 0.995–1.000 0.984 0.977–0.989 0.961 0.949–0.970
Circulatory system diseases 2177 55.4 ± 19.7 35.2 0.982 0.975–0.987 0.917 0.903–0.929 0.800 0.776–0.821
Diseases of the musculoskeletal system and connective tissue 1826 57.3 ± 15.5 18.9 0.973 0.964–0.980 0.892 0.875–0.907 0.768 0.740–0.794
Metabolic diseases 1773 36.7 ± 28.0 58.2 0.962 0.951–0.963 0.899 0.883–0.914 0.845 0.822–0.865
Respiratory diseases 1639 60.1 ± 16.4 57.3 0.947 0.934–0.957 0.719 0.687–0.749 0.565 0.520–0.608
Diseases of the skin and subcutaneous tissue 1413 58.9 ± 22.3 43.9 0.949 0.936–0.960 0.811 0.786–0.833 0.715 0.677–0.748
Diseases of the blood and blood-forming organs 1361 27.9 ± 22.3 48.6 0.992 0.986–0.996 0.972 0.960–0.981 0.962 0.947–0.973
Immune system disorders 1331 38.5 ± 23.0 38.8 0.998 0.994–1.000 0.969 0.956–0.979 0.903 0.875–0.925
Disorders of the eye and adnexa 1301 37.5 ± 18.6 57.3 0.998 0.993–0.999 0.989 0.981–0.994 0.964 0.947–0.975
Endocrine diseases 1036 24.1 ± 20.5 26.7 1.000 0.988 0.976–0.994 0.957 0.933–0.973
Neoplasms 987 31.5 ± 22.7 45.2 0.986 0.977–0.992 0.944 0.926–0.958 0.923 0.899–0.941
Diseases of the genitourinary system 489 43.0 ± 20.5 47.8 0.996 0.983–0.999 0.989 0.971–0.996 0.954 0.907–0.977
Digestive disorders 257 51.1 ± 21.4 53.7 0.968 0.936–0.984 0.896 0.841–0.933 0.818 0.720–0.884
1infectious and parasitic diseases 13 47.2 ± 19.7 53.8 1.000 0.909 0.508–0.987 0.909 0.508–0.987
Total 23,671 44.3 ± 25.0 46.0 0.973 0.9710.975 0.888 0.8840.893 0.808 0.8010.815

Bold is provided for total rare disease survival results

aOnly cases diagnosed beyond 1 month. The total number of cases shown in the table does not refer to the sum of cases for each nosological group. Survival estimates of neonatal morbidities of perinatal origin not shown as only 6 cases were reported. 95% CI 95% confidence interval